Cargando…
Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic
Autores principales: | NORIS-GARCÍA, ELENA, ROBINSON-AGRAMONTE, MARIA DE LOS ANGELES, GONÇALVES, CARLOS-ALBERTO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130637/ https://www.ncbi.nlm.nih.gov/pubmed/35637047 http://dx.doi.org/10.1016/j.arcmed.2022.05.004 |
Ejemplares similares
-
Impact of SARS-CoV-2 on neuropsychiatric disorders
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2021) -
Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic
por: Zhou, Si-Yu, et al.
Publicado: (2022) -
Bone remodeling serum markers in children with systemic lupus erythematosus
por: Hao, Sheng, et al.
Publicado: (2022) -
COVID-19 and the Nervous System from a Cuban Experience
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2023) -
SARS-CoV-2 and Systemic Lupus Erythematosus
por: Thanou, Aikaterini, et al.
Publicado: (2021)